FIORENTINO, MAURO
FIORENTINO, MAURO
Adjuvant chemotherapy and chemoimmunotherapy for gastric carcinoma
1989-01-01 Lise, M.; Nitti, D.; Marchet, A.; Kalamian, H.; Fornasiero, Antongiulio; Fiorentino, Mauro; Farinati, F.; Di Mario, F.
Correction to: Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer (Cancers, (2020), 12, 3, (666), 10.3390/cancers12030666)
2025-01-01 Cavazzoni, A.; Digiacomo, G.; Alfieri, R.; La Monica, S.; Fumarola, C.; Galetti, M.; Bonelli, M.; Cretella, D.; Barili, V.; Zecca, A.; Giovannetti, E.; Fiorentino, M.; Tiseo, M.; Petronini, P. G.; Ardizzoni, A.
INCREASED SOLUBLE AND MEMBRANE-BOUND PD-L1 EXPRESSION IN NSCLC CELL LINES TREATED WITH PEMETREXED
2018-01-01 Cavazzoni, A.; Digiacomo, G.; Petronini, P. G.; Fiorentino, M.; Ardizzoni, A.; Alfieri, R.
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer
2020-01-01 Cavazzoni, A.; Digiacomo, G.; Alfieri, R.; La Monica, S.; Fumarola, C.; Galetti, M.; Bonelli, M.; Cretella, D.; Barili, V.; Zecca, A.; Giovannetti, E.; Fiorentino, M.; Tiseo, M.; Petronini, P. G.; Ardizzoni, A.
The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice
2022-01-01 De Maglio, G.; Pasello, G.; Dono, M.; Fiorentino, M.; Follador, A.; Sciortino, M.; Malapelle, U.; Tiseo, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adjuvant chemotherapy and chemoimmunotherapy for gastric carcinoma | 1-gen-1989 | Lise, M.; Nitti, D.; Marchet, A.; Kalamian, H.; Fornasiero, Antongiulio; Fiorentino, Mauro; Farinati, F.; Di Mario, F. | |
| Correction to: Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer (Cancers, (2020), 12, 3, (666), 10.3390/cancers12030666) | 1-gen-2025 | Cavazzoni, A.; Digiacomo, G.; Alfieri, R.; La Monica, S.; Fumarola, C.; Galetti, M.; Bonelli, M.; Cretella, D.; Barili, V.; Zecca, A.; Giovannetti, E.; Fiorentino, M.; Tiseo, M.; Petronini, P. G.; Ardizzoni, A. | |
| INCREASED SOLUBLE AND MEMBRANE-BOUND PD-L1 EXPRESSION IN NSCLC CELL LINES TREATED WITH PEMETREXED | 1-gen-2018 | Cavazzoni, A.; Digiacomo, G.; Petronini, P. G.; Fiorentino, M.; Ardizzoni, A.; Alfieri, R. | |
| Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer | 1-gen-2020 | Cavazzoni, A.; Digiacomo, G.; Alfieri, R.; La Monica, S.; Fumarola, C.; Galetti, M.; Bonelli, M.; Cretella, D.; Barili, V.; Zecca, A.; Giovannetti, E.; Fiorentino, M.; Tiseo, M.; Petronini, P. G.; Ardizzoni, A. | |
| The storm of NGS in NSCLC diagnostic-therapeutic pathway: How to sun the real clinical practice | 1-gen-2022 | De Maglio, G.; Pasello, G.; Dono, M.; Fiorentino, M.; Follador, A.; Sciortino, M.; Malapelle, U.; Tiseo, M. |